Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05797558 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Unilateral Primary Aldosteronism, Mineralocorticoid Antagonists Versus Surgical Treatment

Study acronym: UPA-MEST
StatusRecruiting
PhaseNot applicable
Started2023-04-28
View on ClinicalTrials.gov ↗

Amendment history

2025-04-03
Study Status, Oversight v2
Primary completion date2027-02→2028-05-28
Completion date2027-02→2028-05-28
2023-04-28
Not Yet Recruiting→Recruiting Study Status, Contacts/Locations v1
Trial statusNot Yet Recruiting→Recruiting
Start dateestimated 2023-04-15→confirmed 2023-04-28
Study sitesdetails revised at 3 of 3 sites
2023-03-30
Original filing
This is a prospective randomized controlled trial where quality of life and the effectiveness of treatment will be evaluated in 80 patients with confirmed unilateral primary aldosteronism ,randomly assigned to be either treated surgically with unilateral adrenalectomy or to receive medical treatment with eplerenone.
Trial Details
NCT Number NCT05797558
Lead Sponsor Göteborg University
Collaborators: Karolinska Institutet, Umeå University
Conditions Primary Hyperaldosteronism Due to Adrenal Adenoma
Enrollment 80 participants
Start Date 2023-04-28
Primary Completion 2028-05-28 (estimated)
Study Completion 2028-05-28 (estimated)
Updated on ClinicalTrials.gov 2025-04-06